Osaic Holdings’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Osaic Holdings’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-601	Closed	-$4.01K	–	7529
2023 Q3	$4.01K	Sell	601 -290	-33%	-$2.41K	﹤0.01%	6367
2023 Q2	$8.07K	Sell	891 -1,779	-67%	-$15.7K	﹤0.01%	6077
2023 Q1	$19.4K	Hold	2,670	–	–	﹤0.01%	5590
2022 Q4	$19K	Hold	2,670	–	–	﹤0.01%	5616
2022 Q3	$21K	Hold	2,670	–	–	﹤0.01%	5566
2022 Q2	$18K	Hold	2,670	–	–	﹤0.01%	5699
2022 Q1	$21K	Hold	2,670	–	–	﹤0.01%	5669
2021 Q4	$15K	Buy	+2,670	New	+$20K	﹤0.01%	6014
2021 Q1	–	Sell	-100	Closed	-$1K	–	7002
2020 Q4	$1K	Buy	+100	New	+$1.39K	﹤0.01%	6309

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings's PNT Position: Q4 2023 in Review

Osaic Holdings sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 601 shares — an estimated $4.01K sold.

Osaic Holdings first reported a position in PNT in Q4 2020 and held it in 9 quarters. The position peaked at $21K in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Osaic Holdings reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 601 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $4.01K.
Osaic Holdings first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2020 and held it in 9 quarters.
Osaic Holdings's POINT Biopharma Global Inc. Common Stock position peaked at $21K in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.